MedTech Resources

Device type · OBP

Transcranial Magnetic Stimulator

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about OBP: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

OBP

Neurology

Device class

Class II

FDA decisions since 2015

64

510(k), De Novo and PMA

Adverse event reports

51

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Transcranial Magnetic Stimulator
Product code
OBP
Device class
Class II
Review panel
Neurology
Regulation
21 CFR 882.5805

Latest FDA decisions

The 8 newest of 64 since 2015.

All decisions for OBP

Reports received

51

Received Nov 1, 2025 to Nov 19, 2026. Includes 2 of another or unstated type.

Malfunction reports

2

3.9% of reports

Injury reports

47

92% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 230300
Jan 240600
Feb 240300
Mar 240800
Apr 240900
May 240100
Jun 241700
Jul 240100
Aug 240000
Sep 240200
Oct 240200
Nov 240800
Dec 240200
Jan 250200
Feb 251300
Mar 250300
Apr 250800
May 2502200
Jun 2501000
Jul 250800
Aug 250600
Sep 2501100
Oct 250300
Nov 250200
Dec 250400
Jan 260300
Feb 260600
Mar 260500
Apr 260700
May 260200
Jun 262300
Jul 260600
Aug 260101
Sep 260400
Oct 260401
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Adverse Event Without Identified Device or Use Problem26
  • Patient Device Interaction Problem4
  • Patient-Device Incompatibility3
  • Off-Label Use2
  • Use of Device Problem2
  • Improper or Incorrect Procedure or Method1
  • Insufficient Cooling1

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Convulsion/Seizure14
  • Headache12
  • Anxiety9
  • Emotional Changes8
  • Unspecified Mental, Emotional or Behavioral Problem7
  • Depression5
  • Cognitive Changes4
  • Eye Pain4
  • Fatigue4
  • Memory Loss/Impairment4

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.